collecting duct RCC

• 

Cabozantinib for collecting duct carcinoma

By Sharon Deveson Kell|2022-04-26T13:39:28+00:0026 Apr 2022|Drug treatments, Subtypes of RCC|

Collecting duct carcinoma is a rare and aggressive form of [...]

Read More

Comments Off on Cabozantinib for collecting duct carcinoma

• 

EIKCS 2022: Treatment for non-clear cell kidney cancer subtypes

By Sharon Deveson Kell|2022-04-26T08:39:32+00:0026 Apr 2022|Drug treatments, Subtypes of RCC|

At the European International Kidney Cancer Symposium (EIKCS) in Antwerp, [...]

Read More

Comments Off on EIKCS 2022: Treatment for non-clear cell kidney cancer subtypes

• 

Diagnosis and treatment of collecting duct carcinoma of the kidney

By Sharon Deveson Kell|2022-03-15T08:22:06+00:0015 Mar 2022|Drug treatments|

Collecting duct carcinoma of the kidney is a very aggressive [...]

Read More

Comments Off on Diagnosis and treatment of collecting duct carcinoma of the kidney

• 

ESMO 2021: Cabozantinib for collecting duct carcinoma – the BONSAI study

By Sharon Deveson Kell|2021-09-21T08:06:07+00:0021 Sep 2021|Drug treatments|

Metastatic collecting duct carcinoma is an aggressive form of RCC, [...]

Read More

Comments Off on ESMO 2021: Cabozantinib for collecting duct carcinoma – the BONSAI study

• 

Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma

By Sharon Kell|2020-04-06T10:00:28+00:006 Apr 2020|Uncategorized|

In this video interview from Practice Update, Dr Brad McGregor [...]

Read More

Comments Off on Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma